Loading...
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
BACKGROUND: BRAF V600 mutations occur in various nonmelanoma cancers. We undertook a histology-independent phase 2 “basket” study of vemurafenib in BRAF V600 mutation–positive nonmelanoma cancers. METHODS: We enrolled patients in six prespecified cancer cohorts; patients with all other tumor types w...
Na minha lista:
| Udgivet i: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4971773/ https://ncbi.nlm.nih.gov/pubmed/26287849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1502309 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|